Part 4731.4459 - OPHTHALMIC USE OF STRONTIUM-90; TRAININGExcept as provided under part 4731.4414, a licensee must require an authorized user of strontium-90 for ophthalmic radiotherapy to be a physician who:
A. is an authorized user under part 4731.4458 or equivalent requirements of the NRC or an agreement state; orB. has: (1) completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy. The training must include: (a) radiation physics and instrumentation;(b) radiation protection;(c) mathematics pertaining to the use and measurement of radioactivity; and(2) had supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution, clinic, or private practice that includes the use of strontium-90 for the ophthalmic treatment of five individuals. The supervised clinical training must involve:(a) examination of each individual to be treated;(b) calculation of the dose to be administered;(c) administration of the dose; and(d) follow up and review of each individual's case history; and(3) obtained written attestation, signed by a preceptor authorized user who meets the requirements of this part, part 4731.4414, or 4731.4458, or equivalent requirements of the NRC or an agreement state, that the individual has satisfactorily completed the requirements in subitems (1) and (2) and is able to independently fulfill the radiation safety-related duties as an authorized user of strontium-90 for ophthalmic use.Minn. R. agency 144, ch. 4731, MEDICAL USE OF RADIOACTIVE MATERIAL, pt. 4731.4459
29 SR 755; 32 SR 831; 36 SR 74Statutory Authority: MS s 144.1202; 144.1203